Long-term albumin infusion improves survival in patients with cirrhosis and ascites: An unblinded randomized trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

709

HTML

4030

Figures (1-1)

138

Tables (1-2)

142

Sum=5019

Mar 7, 2006 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Mar 7, 2006; 12(9): 1403-1407
Published online Mar 7, 2006. doi: 10.3748/wjg.v12.i9.1403

Figure 1 Cumulative survival rate in group 1 (albumin) and group 2 patients. Breslow test = 7.05; P = 0.0079.

Citation: Romanelli RG, Villa GL, Barletta G, Vizzutti F, Lanini F, Arena U, Boddi V, Tarquini R, Pantaleo P, Gentilini P, Laffi G. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: An unblinded randomized trial. World J Gastroenterol 2006; 12(9): 1403-1407
URL: https://www.wjgnet.com/1007-9327/full/v12/i9/1403.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i9.1403